We are live on ! Find out more
CIP

Convergence Investment Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+87.75%
3 Year Est. Return
+284.26%
5 Year Est. Return
+379.02%
10 Year Est. Return
+1,390.46%
AUM
$287M
AUM Growth
-$3.42M
Cap. Flow
-$16.8M
Cap. Flow %
-5.84%
Top 10 Hldgs %
17.3%
Holding
280
New
70
Increased
46
Reduced
113
Closed
51

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$2.77M
2
GS icon
Goldman Sachs
GS
+$1.9M
3
QCOM icon
Qualcomm
QCOM
+$1.68M
4
AAPL icon
Apple
AAPL
+$1.59M
5
NVDA icon
NVIDIA
NVDA
+$1.58M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Healthcare 14.87%
3 Financials 14.21%
4 Consumer Discretionary 11.47%
5 Industrials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
201
Thermo Fisher Scientific
TMO
$220B
$364K 0.13%
825
-90
-10% -$37.2K
RDN icon
202
Radian Group
RDN
$4.91B
$350K 0.12%
23,983
-10,735
-31% -$160K
UPWK icon
203
Upwork
UPWK
$1.2B
$347K 0.12%
+19,886
New +$298K
ACN icon
204
Accenture
ACN
$108B
$341K 0.12%
1,507
-76
-5% -$17.4K
BIPC icon
205
Brookfield Infrastructure
BIPC
$4.78B
$340K 0.12%
+9,215
New +$306K
MDT icon
206
Medtronic
MDT
$113B
$328K 0.11%
3,153
-65
-2% -$6.53K
UPS icon
207
United Parcel Service
UPS
$88.4B
$323K 0.11%
1,938
-4
-0.2% -$582
BMY icon
208
Bristol-Myers Squibb
BMY
$133B
$322K 0.11%
5,336
-16,431
-75% -$989K
MOS icon
209
The Mosaic Company
MOS
$7.19B
$319K 0.11%
+17,438
New +$284K
DHR icon
210
Danaher
DHR
$145B
$301K 0.1%
1,577
-87
-5% -$15.5K
CHTR icon
211
Charter Communications
CHTR
$17.9B
$294K 0.1%
470
-7
-1% -$4.13K
LLY icon
212
Eli Lilly
LLY
$1.08T
$292K 0.1%
1,972
-404
-17% -$62.5K
HON icon
213
Honeywell
HON
$77.5B
$283K 0.1%
1,825
-39
-2% -$5.79K
FUL icon
214
H.B. Fuller
FUL
$3.25B
$274K 0.1%
+5,977
New +$282K
NEE icon
215
NextEra Energy
NEE
$177B
$272K 0.09%
3,920
-14,996
-79% -$1.04M
TNL icon
216
Travel + Leisure Co
TNL
$4.54B
$262K 0.09%
8,529
-26,362
-76% -$787K
SBUX icon
217
Starbucks
SBUX
$120B
$259K 0.09%
3,015
-69
-2% -$5.5K
LIN icon
218
Linde
LIN
$226B
$256K 0.09%
+1,076
New +$261K
CI icon
219
Cigna
CI
$74.3B
$252K 0.09%
1,490
+328
+28% +$57.7K
BA icon
220
Boeing
BA
$186B
$250K 0.09%
1,513
+123
+9% +$21K
RTX icon
221
RTX Corp
RTX
$305B
$249K 0.09%
4,335
+575
+15% +$35K
ELV icon
222
Elevance Health
ELV
$86.3B
$239K 0.08%
891
+5
+0.6% +$1.34K
COR icon
223
Cencora
COR
$62B
$220K 0.08%
2,268
-27,827
-92% -$2.77M
AXP icon
224
American Express
AXP
$229B
$219K 0.08%
2,186
-13
-0.6% -$1.28K
FDX icon
225
FedEx
FDX
$76.3B
$219K 0.08%
+871
New +$174K

Similar funds

Convergence Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Convergence Investment Partners held 280 positions worth $287M, down 1.2% from $291M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Convergence Investment Partners withdrew a net $16.8M in Q3 2020, closing 51 positions and reducing 113 holdings. Its most notable exit was Goldman Sachs, an estimated $1.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Convergence Investment Partners opened a new position in Bank of New York Mellon worth $1.85M.

  • Convergence Investment Partners's largest Q3 2020 buy was Bank of New York Mellon: 53,779 shares worth $1.85M.
  • Convergence Investment Partners added most to Pfizer in Q3 2020, an estimated $2.29M increase.
  • Convergence Investment Partners's biggest Q3 2020 reduction was Cencora, cutting an estimated $2.77M.
  • Convergence Investment Partners fully exited Goldman Sachs in Q3 2020, selling an estimated $1.9M.
  • Convergence Investment Partners's ten largest holdings make up 17% of its $287M portfolio in Q3 2020.
  • Convergence Investment Partners opened 70 new positions and closed 51 in Q3 2020.
  • Convergence Investment Partners's portfolio value fell 1.2% quarter-over-quarter to $287M.

Based on Convergence Investment Partners's 13F filing for Q3 2020, filed 28 Oct 2020.